Personalized Medicine: Tailoring Treatment to the Individual (Expanded)
Personalized Medicine: Tailoring Treatment to the Individual (Expanded) The paradigm of ovarian cancer treatment in 2025 is increasingly shifting towards a more personalized approach, recognizing that each patient's cancer is unique at the molecular level. Advancements in genomics, molecular profiling, and artificial intelligence are empowering clinicians in Nagpur, across India, and globally to better understand the specific characteristics of an individual's tumor and tailor treatment strategies for optimal efficacy and minimal toxicity. Biomarker Testing: Guiding Targeted Therapies: Comprehensive genomic testing of tumor tissue has become an increasingly integral part of the diagnostic and treatment planning process for ovarian cancer. Next-generation sequencing (NGS) can identify a wide range of genetic mutations, gene fusions, and other molecular alterations within the tumor cells. This information is crucial for determining a patient's eligibility for targ...